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The neonatal Fc receptor (FcRn) in intestinal epithelium is the primary mechanism for
transfer of maternal immunoglobulin G (IgG) from suckled milk to serum; but the factors
contributing to the rapid uptake of IgG are poorly understood. These studies help to
determine the contribution of cell surface FcRn in IgG uptake in 2-week-old rat pups
by varying local pH and binding conditions. Variants of a human wild-type (WT) IgG
monoclonal antibody (mAb WT) were assessed for binding afﬁnity (KD) to rat (r)FcRn at
pH 6.0 and subsequent off-rate at pH 7.4 (1/s) by surface plasmon resonance. Selected
mAbs were administered intra-intestinally in isoﬂurane-anesthetized 2-week rat pups. Full
lengthmAb in serumwas quantiﬁed by immunoassay, (r)FcRnmRNAexpression by reverse
transcription polymerase chain reaction, and mAb epithelial localization was visualized
by immunohistochemistry. After duodenal administration, serum levels of mAb variants
correlated with their rFcRn off-rate at pH 7.4, but not their afﬁnity at pH 6.0. The greatest
serum levels of IgG were measured when mAb was administered in the duodenum where
rFcRn mRNA expression is greatest, and was increased further by duodenal administration
in pH 6.0 buffer. More intense human IgG immunostaining was detected in epithelium than
the same variant administered at higher pH.These data suggest an increased contribution
for cell surface receptor. We conclude that, in the neonate duodenum, receptor off-rates
are as important as afﬁnities for FcRn mediated uptake, and cell surface binding of IgG to
rFcRn plays contributes to IgG uptake alongside pinocytosis; both of which responsible for
increased IgG uptake.
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INTRODUCTION
Neonatal Fc receptors bind to the Fc portion of IgGs and
function in infant mammalian physiology to facilitate trans-
port of IgG from the placenta to the fetus, and from suckled
maternal milk into the neonatal circulation (Brambell, 1966,
1969; Rodewald and Kraehenbuhl, 1984). Beyond mammalian
infancy, FcRn is still expressed in the intestine at much lower
levels (Hornby et al., 2013), but most commonly found con-
stitutively expressed in the endothelium, and is responsible for
the increased half-life of IgGs in the circulation (Roopenian and
Akilesh, 2007).
Endothelial cells take up surrounding ﬂuids and solutes
(including all Igs), by pinocytosis to form intra-cellular vesicles to
collect nutrients for the cell or to breakdown unwanted particles
in the circulation. Within these endosomes, conditions become
slightly acidic (pH 6.0) and favorable for the interaction between
FcRn molecules and the Fc portion of IgGs. Unbound IgGs, all
IgAs and IgMs, and other unwanted materials are broken down by
Abbreviations: FcRn, neonatal Fc receptor; IgG, immunoglobulin G;WT, wild
type.
lysosomes. FcRn bound IgGs are recycled back to the cell surface,
disassociate from the FcRn in neutral (pH 7.4) conditions and
released back into the circulation (Brambell, 1966, 1969; Raghavan
et al., 1995).
In contrast to the endothelial cells, the FcRn–IgG complex is
transcytosed through the intestinal epithelium cell and is released
on the basolateral side, disassociated and the IgG and is released
into the lymphatic system, where it enters the circulation via the
thoracic lymph nodes (Swartz and Skobe, 2001; Kliwinski et al.,
2013). The mechanism of internalization of IgG in epithelial cells
remains quite controversial as to whether pinocytosis and cell
surface FcRn receptors both contribute (Benlounes et al., 1995;
Mohanty et al., 2013). Evidence suggests that FcRn receptors are
locatedon the cell surface of enterocytes (Israel et al., 1997;Hornby
et al., 2013); suggesting that IgG internalization could occur by cell
surface binding and uptake in epithelial cells.
The intestinal system of neonates is adapted to these chal-
lenges by having a reduced level of secreted protease enzymes, an
under-developed intestinal epithelial layer, and increased expres-
sion of FcRn on the luminal side of intestinal epithelial cells
(Udall et al., 1981; Norin et al., 1986; Telleman and Junghans,
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2000). Therefore, neonates, such as suckling rat pups, may
serve as a suitable mechanistic in vivo model for IgG transcytosis
(Rodewald and Kraehenbuhl, 1984; Benlounes et al., 1995; Martin
et al., 1997).
We previously showed that Tg276 transgenic mice that express
human FcRn in the intestinal mucosa do not functionally trans-
port human IgG after intestinal administration (Kliwinski et al.,
2013). When human IgG was administered to the small intes-
tine of 2-week-old suckling rat pups, approximately 80% of
the uptake was FcRn-dependent while the remaining ∼20% was
FcRn-independent and non-receptor mediated (Kliwinski et al.,
2013).
The present study aims to further characterize the pharmaco-
logical interactions between IgG and FcRn that contribute to the
rapid uptake of IgG in the neonatal rat, including FcRn afﬁnity
and off-rates, pH-dependence, the effect of differential intestinal
administration sites, and aims to increase evidence that cell surface
receptors have a role.
MATERIALS AND METHODS
DETERMINING THE AFFINITY AND OFF-RATES OF HUMAN IgG
VARIANTS TO RAT FcRn
The mAbs used in this study were a recombinant chimeric human
IgG1 monoclonal antibody speciﬁc for human respiratory syncy-
tial virus (RSV), also known as B21M. TheWT and FcRn binding
afﬁnity variants (H435A, N434A, and N434Y) with mutations at
the 434 and 435 amino acid positions (EU numbering; Firan et al.,
2001; Yeung et al., 2009; Deng et al., 2012) were tested for bind-
ing afﬁnity to rat FcRn. In addition to determining the afﬁnity of
humanmAbs to rat FcRn at pH 6.0 and 7.4we developed amethod
to determine the off-rate of pre-bound (at pH 6.0) mAb after the
buffer conditions were changed to pH 7.4.
GLC biosensor chip conditioning and Rat FcRn immobilization
A ProteOn XPR36 GLC biosensor chip (Bio-Rad, Hercules, CA,
USA) was preconditioned with 0.5% sodium dodecyl sulfate
(SDS), 50 mM NaOH and 100 mM HCl in both the vertical (lig-
and) and horizontal (analyte) channels. Following equilibration
with PBS-TE running buffer (20 mM Na-phosphate, 150 mM
NaCl, 0.005% Tween-20, 3 mM EDTA, pH 6.0), FcRn was immo-
bilized using an amine coupling kit at a temperature of 25◦C
and a ﬂow rate of 30 μl/min. All channels were activated with
a mixture of EDC [1-Ethyl-3-(3-dimethylaminopropyl) carbodi-
imide] (0.2 M) and sulfo-NHS (0.05 M) at 30 μl/min for 4 min,
followed immediately by immobilization of rat FcRn (3 μg/mL
in 10 mM sodium acetate pH 4.5) over channels 1 and 2 at
30 μL/min for 5 min. The reference channel was treated iden-
tically without injection of FcRn. All channels were then blocked
for 5 min with an injection of 1 M ethanomine-HCl (pH 8.5).
This method resulted in rat FcRn coupled at response levels of
193 and 161 RU (1 RU = 1 pg protein/mm2) in channels 1 and 2,
respectively.
Analysis of afﬁnity between rat FcRn and IgG variants at pH 6.0
Following immobilization, the four IgG1 (WT, N434A, N434Y,
and H435A) mAb variants were diluted with running buffer for-
mulated at pH 6.0. Each mAb was tested at ﬁve concentrations in
duplicate using a ﬁvefold dilution series. The ﬁve concentrations
of each analyte were injected simultaneously at a ﬂow rate of
60 μL/min for a 1 min association phase which was followed by
a 3 min dissociation phase. The surface was regenerated prior to
each subsequent mAb and tested with two injections of sodium
phosphate (pH 8.0) followed by one injection of running buffer
(pH 6.0). Afﬁnity analysis and kinetic constants were calculated
from the sensorgrams using the bivalent analyte model of the
ProteOn XPR36 software.
Analysis of off-rate between rat FcRn and IgG variants at pH 7.4
using the ProteOn co-injection mode
Following immobilization, the four IgG1 mAb variants were
diluted with running buffer formulated at pH 6.0. Each mAb was
tested at ﬁve concentrations in duplicate using a ﬁvefold dilu-
tion series. The ﬁve concentrations of each analyte were injected
simultaneously at a ﬂow rate of 60 μL/min for a 1 min associa-
tion phase immediately followed by a co-injection step in which
running buffer formulated at pH 7.4 (with no IgG present) was
injected for a 3 min dissociation phase. The surface was regener-
ated prior to each subsequent mAb tested with two injections of
sodium phosphate (pH 8.0) followed by one injection of running
buffer (pH 6.0). Off-rate analysis was evaluated using ProteOn
XPR36 software.
Intra-intestinal dosing. Rat pups, 12–17 days-old (male or
female), were kept with their dams in plastic ﬁlter-topped cages
until 30 min prior to the start of each experiment. The animals
were placed in a chamber for induction of anesthesia with isoﬂu-
rane (initially 2–4%) and then removed and placed supine on
a surgical pad maintained at 37◦C with a nose cone for mainte-
nance of anesthesia (2% isoﬂurane). Animalswere prepared for the
surgical procedure, which consisted of a laparotomy followed by
exteriorization of the stomach and start of the small intestine using
minimal disturbance. A bolus injection of test article (1 mg/kg)
was made into either the proximal small intestine (duodenum) or
the distal small intestine (ileum), depending on the study, via a 27 g
needle. A retro-orbital blood draw of approximately 100μL 5min
after test article administration, and a terminal intracardiac with-
draw was performed at 90 min. All blood samples were allowed to
stand for at least 30 min, but no longer than 1 h, centrifuged at
3500 rpm for 10min and the serum separated and stored at−80◦C
until analyzed. The entire intestine was also removed and cleaned
of mesenteric attachments and laid out to its full length without
stretching. The small intestine divided into thirds, and the prox-
imal colons (∼3 cm from the cecum) were collected from each
rat pup. The tissue plus luminal contents were added to individual
2-mL tubes containing 250μL of rat serumwith protease inhibitor
cocktail at a ﬁnal concentration of one tablet/10 mL and kept on
ice for at least 30min. All samples were centrifuged at 3500 rpm for
10 min and the supernatant separated and stored at −80◦C until
valuated. Care was taken to perform the surgical procedure fol-
lowing aseptic techniques and a surgical plane of anesthesia was
maintained throughout the entire procedure. All animal studies
were performed in accordance with the Federal Animal Welfare
Act and protocols were approved by the Institutional Animal Care
and Use Committee (IACUC) at Janssen R&D.
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Intact IgG analysis. Full length IgG antibodies were quantiﬁed
using the Meso Scale Discovery (MSD) electrochemiluminescent
assay as previously described (Hornby et al., 2013; Kliwinski et al.,
2013). The mAbs used in this study were a recombinant chimeric
human IgG1 monoclonal antibody speciﬁc for human RSV, also
known as B21M. An anti-idiotypic antibody speciﬁc for the anti-
RSV IgGs was labeled with sulfo-NHS-LC-biotin and used as a
capture antibody. A pan anti-human IgG1/IgG2 antibody labeled
with MSD Sulfo-TAG NHS Ester was used as the detection anti-
body. A standard curve for the anti-RSV IgGs in neat rat serumwas
observed over the range of 50,000 pg/mL–50 pg/mL. The lower
limit of quantiﬁcation (LLOQ) was 0.5 ng/mL using 25 μL of
neat rat serum. Serum and intestinal content levels of intact IgG
antibodies are reported as mean ± SEM (ng/mL).
FcRn RT-PCR. Mucosal scrapings from rat pup duodenum, ileum,
and proximal colon were snap frozen immediately following
sample collection. Scrapings were placed into FastPrep lysing
tubes with 500 μL lysis buffer and rapidly shaken for 60 s. The
homogenous sample (350 μL) was used to make RNA using the
QIAGEN RNAeasy Kit (Valencia, CA, USA). RNA concentration
was conﬁrmed using the NanoDrop spectrophotometer (Invitro-
gen, Carlsbad, CA, USA). RNA integrity was established using
the RNA Nano 6000 Kit and read on an Agilent 2100 Bioana-
lyzer (Santa Clara, CA, USA). RNA was stored at −80◦C. The
cDNA was made using a reverse transcription kit from Applied
Biosystems (Carlsbad, CA, USA) from approximately 0.3–1.0 μg
of RNA and stored at −20◦C. Reverse transcription polymerase
chain reaction (RT-PCR) samples were prepared in triplicate with
the following: 2×TaqmanUniversal PCRMasterMix (10μL), dis-
tilled water (8 μL), 20× primer and probe mix (1 μL) and cDNA
(1 μL; 20–50 ng). The cycle threshold (Ct) was normalized to
rat housekeeping gene, hypoxanthine phosphoribosyltransferase
(HPRT). The intestinal segment with the lowest Ct value relative
to the housekeeping gene was arbitrarily used as the comparator
for the remaining three gut sections (proximal colon for rat). A
fold change with respect to the proximal colon was performed
using a delta–delta Ct method which involved normalization to
a housekeeping gene and fold change with respect to a particular
gut section.
The primer and probe sets used were: Rat B2M, Rn00560865,
Rat FcRn, Rn00583712, Rat HPRT,Rn01527840, and Rat GAPDH,
Rn99999916 (Applied Biosystems).
Immunohistochemistry. Following intra-duodenal administra-
tion of IgG variants, a 1-cm section of the duodenumwas removed
and laid ﬂat between two pieces of biopsy sponge and ﬁxed in 10%
neutrally buffered formalin (NBF). Tissues were exposed to an
increasing alcohol gradient and 5-micron sections were cut from
each tissue block sample and de-waxed. A steam heat-induced
epitope recovery pretreatment system (SHIER2) was used fol-
lowed by a goat block and the primary antibody, human IgG1
(1 μg/mL; 1 hr; Epitomics). A biotinylated goat anti-rabbit IgG
was then incubated with the sections, followed by a hydrogen per-
oxide block and the ABC (avidin/biotin complex) reagent. The
3,3′-diaminobenzidine (DAB) chromogen was added followed by
a hematoxylin counterstain and dehydration. Specimens were
cover-slipped with glass and Permount™. The above procedures
were completely automated using the TechMate 500 (BioTek
Solutions). Positive staining was indicated by the presence of a
brown chromogen (DAB-HRP) reaction product. Hematoxylin
counterstaining provided a blue nuclear stain to assess cell and
tissue morphology. Representative images were obtained with an
Olympus Microﬁre digital camera (M/N S97809) attached to an
Olympus BX60 microscope. Images were graded on a scale of 0–3
by a blinded investigator.
RESULTS
AFFINITY AND OFF-RATES OF IgG1 VARIANTS TO RAT FcRn AT pH 6.0
AND 7.4
We developed methodology to mimic the effect from pH change
of pH 6.0 to pH 7.4 on IgG-FcRn binding, which enabled deter-
mination of the off-rates of pre-bound mAb. Four human IgG1
variants were passed over the rat-FcRn pre-coated ProteOn chip
in separate lanes for one min at pH 6.0 at ﬁve different concentra-
tions between 1.6 and 1000 nM in duplicate. Sufﬁcient time was
allowed for Fc-FcRn association to determine afﬁnities after which
the media was changed to PBS-TE (pH 7.4) without the IgG vari-
ants to determine FcRn off-rates. Afﬁnities to FcRn in increasing
order were WT: 169 ± 8.8 nM, N434A: 77 ± 0.2 nM, and N434Y:
27± 3.6 nM (Table 1). TheH435A variant did not bind to FcRn at
any concentrations up to 1000 nM (data not shown) at either pH
6.0 or 7.4. The WT and N434A variants completely disassociated
from FcRn at a faster rate (Figures 1A,B, respectively) than the
N434Y variant at pH 7.4, which still had afﬁnity to FcRn at this
pH (Figure 1C).
SERUM LEVELS OF IgG CORRELATE WITH RAT FcRn pH 6.0 TO 7.4
OFF-RATES
Serum samples at 5 and 90 min following the administration of
either IgG1 WT, N434A, N434Y, or H435A (1 mg/kg) into the
duodenum of sucking rat pups were analyzed for full length IgGs.
Quantities of all IgG1 variants were below the LOQafter 5min and
so served as a baseline reading. The IgG1 N434A variant serum
levels at 90 min of 3483 ± 624 ng/mL (Figure 2A) was trending
slightly higher than levels of theWT variant at 2864 ± 700 ng/mL,
followed by the H435A variant at 630 ± 131 ng/mL. Surprisingly,
the serum level of N434Y after 90 min (195 ± 39 ng/mL) was
low despite previously being shown to have the greatest afﬁnity
to rat FcRn (27 nM). Increasing the length of time after duo-
denal administration to 180 min increased the serum levels of
N434A, WT, H435A, and N434Y to 6040 ± 797, 5840 ± 792,
Table 1 | Affinities and off-rates of IgG1 variants to FcRn.
Affinity to rat FcRn (nM) pH shift (6–7.4)
IgG1 variant pH 6.0 pH 7.4 rFcRn off-rate 1/s (s)
WT 169 ± 8.8 – 0.07 ± 0.0004
N434A 77 ± 0.2 – 0.09 ± 0.001 (11 s)
N434Y 27 ± 3.6 1240 0.02 ± 0.0008 (50 s)
H435A – – –
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FIGURE 1 | Surface plasmon resonance (SPR) analysis using the ProteOn XPR36 in co-injection mode IgG1 variants, (A) wild-type (WT); (B) N434A or
(C) N434Y were diluted 1:5 in a concentration series from 1000 to 1.6 nM, injected over rat FcRn for 1 min in PBS-TE (pH 6.0) and followed
immediately by a co-injection of PBS-TE (pH 7.4) without mAb for 3 min.
1154 ± 351, and 363 ± 53 ng/mL, respectively, but did not
change the relative amounts absorbed by each variant. There
didn’t appear to be a relationship between serum levels detected
and rat FcRn binding afﬁnity, since the highest FcRn afﬁnity
variant, N435Y, had the lowest serum levels (Figure 2B). How-
ever, there was a trend between serum levels and rat FcRn
off-rates at pH 7.4 in that the faster the disassociation from rat
FcRn at pH 7.4, the greater the levels detected in the serum
(Figure 2C).
SERUM LEVELS OF IgG CORRELATE WITH RAT FcRn mRNA EXPRESSION
TheWT IgG1 with a Kd value of 169 nM and the low FcRn afﬁnity
variant, H435A, (Kd > 1 μM) were administered (1 mg/kg) at
the site of the proximal (duodenum) or the distal (ileum) small
intestine of suckling rat pups. Retro-orbital and cardiac bleeds
were taken at 5 and 90 min following administration. Serum
levels of the WT mAb were greater when administered at the
proximal small intestine compared to the distal small intestine
(5833 ± 1561 ng/mL versus 26.9 ± 12.5 ng/mL). The serum
levels of WT after proximal small intestine administration were
greater than the H435A variant administered to the same site
(772 ± 178 ng/mL; P < 0.01). When the variants were adminis-
tered at the distal small intestine, there was no difference between
the WT and H435A variant (Figure 3A).
Reverse transcription polymerase chain reaction was used to
quantify the relative FcRn mRNA expression in the different
regions of the rat intestinal mucosa. Greater amounts of rat FcRn
were detected in the proximal andmid small intestine (Figure 3B),
compared to the distal small intestine and proximal colon.
THE EFFECT OF BUFFER pH ON SERUM UPTAKE OF HIGH AND LOW RAT
FcRn-AFFINITY IgG VARIANTS
Unlike endothelial cells, it is thought that epithelial cells express
FcRn on the cell surface. Suckling rat pups were administered the
rat FcRn binding variant, N434A, or the non-binding variant,
H435A, to the duodenum (0.01 mg/kg). The variants were
administered in pH conditions of 6.0, 7.4, and 8.0. Serum was
collected after 90 min and full length mAb levels were quanti-
ﬁed. The variant with the greater rat FcRn binding afﬁnity variant
was affected by buffer pH in that greater amounts of the vari-
ant were measured in the serum when administered at pH 6.0
(90.2 ± 15.1 ng/mL), compared to levels detected in the serum
when administered at pH 7.4 or 8.0 (P = 0.06 and P = 0.02,
respectively; Figure 4).
Proximal small intestine tissue was collected at 90 min. Anti-
human IgG1 immunostaining was noted at the brush border
epithelium in the proximal small bowel of IgG1-infused rats.
Representative images of immunostaining are shown for each
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FIGURE 2 | Serum levels of IgG correlate with rat FcRn pH 6.0 to 7.4
off-rates: (A) Serum levels (ng/mL) of IgG1 variants (1 mg/kg) 90 min
after intra-duodenal administration in sucking rat pups (n = 5) were
highest for N434A andWT and low as expected for H435A, with N434Y
similar to H435A. One-way Analysis of variance (ANOVA) statistics were
carried out followed by a Bonferroni’s multiple comparison test versusWT.
Serum levels were plotted against (B) Kd afﬁnity constants (nM) to rat FcRn at
pH 6.0 (r2 = 0.43; P = 0.54); and (C) dissociation from FcRn (1/s) at pH 7.4.
after pre-binding at pH 6.0 (r2 = 0.99; P = 0.07). Key: WT;  N434Y; ×
N434A; and  H435A.The H435A has low >1000 nM binding afﬁnity to FcRn,
and its points are only added to (B) and (C) to show the trend. All statistics
carried out excluded the H435A points to avoid bias.
of the three groups (Figure 5) illustrating that the most marked
human IgG immunostaining in enterocytes was visualized when
the high FcRn binding afﬁnity variant was administered at pH
6 (Figure 5B compared to Figure 5C). Immunostaining after
administration of the low FcRn binding variant at pH 8.0 was
also qualitatively less than that visualized with the FcRn bind-
ing variant administered in pH 6.0 buffer. A representative image
from the control group that was infused with PBS, did not show
any human IgG1 immuno-reactivity and was similar to rabbit
IgG control antibody staining (Figure 5A). Semi-quantitative
immunostaining scoring (0 = no staining, and 3 = intense
staining) performed by a histologist blinded to the treatment
supports the pattern of staining shown in the representative
images from each group. Tissue from animals infused with high
afﬁnity FcRn binding variant at pH 6.0 had an average immuno-
reactivity score of 1.5 (Figure 5B) while those infused at pH
8.0 had an immuno-reactivity score of 1.167 (Figure 5C) and
tissue from animals infused with low FcRn binding afﬁnity vari-
ant at pH 8.0 had an average immune-reactivity score of 0.5
(Figure 5D).
DISCUSSION
The present study in neonatal rat intestine demonstrated a
role for both intracellular and cell surface FcRn in the uptake
and transcytosis of IgGs. Consistent with our previous study
(Kliwinski et al., 2013), IgG afﬁnity to FcRn is important for
intestinal to serum uptake; additionally, we now demonstrated
that mAb variant off-rates (Ko), the location of IgG administra-
tion, and pH conditions were also important for FcRn-dependent
uptake. Serumuptakewas increased, when: (1) using variants with
the fastest FcRn off-rates at pH 7.4; (2) administered into the duo-
denumwhere the greatest amount of FcRn is located; and, (3) local
conditions are at pH 6.0 to increase the likelihood of cell surface
FcRn binding and internalization.
We previously demonstrated that transgenicmice incorporated
with human FcRn did not functionally transport human IgG
from the intestine into the circulation (Kliwinski et al., 2013).
We therefore used the suckling rat pup model to demonstrate
the mechanistic pharmacological functions of FcRn and IgG.
Four human IgG variants whose association with human FcRn
has been established (Kuo and Aveson, 2011) were engineered
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FIGURE 3 | Greatest serum levels of IgG measured when administered at
site with greatest rat FcRn mRNA expression: (A) Serum levels of theWT
mAb were measured after 90 min following administration at the
proximal small intestine (S.I; duodenal region) and at the distal S.I
(ileum region) in suckling rat pups (n = 6). A one-way ANOVA followed by
Bonferroni’s multiple comparison test was carried out versus respectiveWT.
(B) mRNA expression of rat FcRn, assessed using reverse transcription
polymerase chain reaction (RT-PCR), from mucosal scrapings of proximal and
distal small intestine, and proximal and distal colon. Data shown is fold
change over proximal colon which had the lowest level of FcRn mRNA).
FIGURE 4 |The effect of pH (pH 6.0, 7.4, and 8.0.) of high and low
FcRn-affinity IgG variants on serum uptake: Serum levels (ng/mL) at
90 min after administration of N434A tended to be higher following
intra-duodenal administration (0.01 mg/kg) in suckling rat pups
(n = 6).There was no difference in the serum levels of H435A administered
in different pH conditions. One-way ANOVA Statistical tests carried out
compared to N434A pH 6.0.
for use in the current study: WT, H435A, N434A, and N435Y.
Previously published studies have shown that a rat FcRn exhib-
ited speciﬁcity for human IgG, but failed to bind to mouse IgG
(Kuo et al., 2009); thus, the afﬁnities of the human (h)IgGs
to rat FcRn were determined. The rank order of afﬁnity
was N434Y >> N434A > WT >> H435A. Following intra-
duodenal administration, the rank order of serum levels was
N434A > WT >> H435A > N434Y. It was surprising that the
variant with the greatest afﬁnity toward rat FcRn was the least
measured in the serum, when it was expected that greater FcRn
afﬁnity would yield greater serum uptake. Quantities of all the
variants in the small intestine after 90 min were comparable sug-
gesting that there was no unforeseen increase in degradation in
the duodenum. The N434A variant has been shown to have a
greater afﬁnity to FcRn, than the WT, across many species (Deng
et al., 2010), resulting in an increased half-life in the circulation.
However, some studies (Gurbaxani et al., 2006; Datta-Mannan
et al., 2007a,b) have not shown a correlation between FcRn afﬁnity
and half-lives, suggesting that other pharmacological properties,
such as off-rates, are important.
The off-rate of pre-bound human IgG to rat FcRn at pH 6.0
was calculated when the buffer was increased to pH 7.4. The rank
order of off-rates was N434A > WT >> N434Y, which corre-
lated with intact IgG levels in the serum. The off-rate at pH 7.4
of the H435A variant could not be measured as it had no cal-
culated binding at pH 6.0. The lower than expected levels of the
N434Y variant in the serum remains bound within the endosome
due to its slow disassociation from, and afﬁnity toward FcRn at
pH 7.4.
In a previously published ex vivo study using rat pup intestinal
segments mounted in Ussing-type ﬂux chambers, IgG transcy-
tosis from the mucosal side was greater in segments from the
proximal than distal small intestine (Benlounes et al., 1995);
however, the mechanisms responsible for this difference were
not elucidated. In the present study we determined that FcRn
mRNA expression is 100-fold higher in the proximal small intes-
tine than the colon, agreeing with previously published studies
showing decreasing levels of FcRn mRNA down the small intes-
tine (Martin et al., 1997). The relative measure of FcRn mRNA
was based on mucosal samples rather than full thickness seg-
ments; therefore, the fold changes in different regions are reﬂective
of epithelial FcRn mRNA expression not FcRn expression in
other cell types such as endothelial and lymphocytes. Consis-
tent with the expression data, signiﬁcantly greater levels of IgG
WT were seen in the serum following administration into the
proximal small intestine compared to the H435A variant. These
results, and those from a previous in-vivo studies, (Martin et al.,
1997; Kliwinski et al., 2013) conﬁrm that an FcRn-dependent
mechanism accounts for a majority of IgG uptake in the prox-
imal small intestine. Also, after administration of IgGs into
the distal small intestine, where FcRn mRNA expression was
much lower, the serum levels of WT were <30 ng/mL and
were similar to levels of the low FcRn binding afﬁnity vari-
ant, H435A suggesting that non-FcRn dependent uptake was
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FIGURE 5 | Increased levels of IgG bound to enterocytes at pH 6.0
compared to pH 8.0: Representative examples of IgG –immuno-reactivity
in enterocytes of suckling rat pup proximal small intestine 90 min after
administration of (A) PBS, (B) IgG1 N434A at pH 6.0, (C) IgG1 N434A at
pH 8.0, and (D) IgG1 H435A at pH 8.0. Images on the left-hand side are
using rabbit anti-human IgG, and the images on the right are using the
anti-rabbit IgG to show speciﬁcity. Images are at 10× magniﬁcation with the
exception of the inserted image in (B) which is 60× magniﬁcation.
primarily contributing to the serum levels after ileum dosing.
Regional uptake in isolated segments of rat pup small intes-
tine in Ussing chambers was attempted in the present study;
however, full-thickness small intestine did not result in any
IgG on the basolateral side 90 min after apical application
and it was too technically challenging to muscle-strip these
fragile tissues without damaging the integrity of the barrier
(detected by FITC-dextran passing across the chamber and the
poor histological appearance of parafﬁn imbedded H&E stained
sections).
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There is a continuing debate as to whether entereocytes express
FcRn on their cell surface, and if the cell surface expression con-
tributes to IgG uptake. An ex vivo study determined that local pH
conditions of 6.0 did not increase the uptake of IgG in neona-
tal proximal small intestine, therefore suggesting that cell surface
receptors were not present and did not amplify cellular uptake
(Benlounes et al., 1995). An ex vivo study concluded that there
was no FcRn present on the jejunum enterocyte surface of weaned
rats, as well as limited FcRn present on neonatal jejunum with
most being intra-cellular (Berryman and Rodewald, 1995). How-
ever, in vitro studies have shown, by ﬂow cytometry, that FcRn
is located on a majority of human intestinal caco-2 cells; and cell
surface IgG binding occurs with a high-afﬁnity FcRn-binding IgG
(Hornby et al., 2013). Using transgenic FcRn+/+ and FcRn−/−
mice strains, one study demonstrated increased amounts of IgG
in the cytoplasmof the knock-out strain verses the over-expressing
concluding Brambell’s hypothesis that receptor-ligand binding
occurs in the cell with no role of FcRn cell surface recep-
tor binding (Mohanty et al., 2013). This result was unexpected,
but could be explained by our previous transgenic studies indi-
cating that this in vivo model may not be ideal to assess the
function and role of entereocyte FcRn (Kliwinski et al., 2013).
The study did indicate that FcRn is required for exocytosis
from the cell (Ober et al., 2004; Mohanty et al., 2013), and
with the assumption that endosome exocytosis occurs both as
a recycling and transcytosis pathway in the enterocyte (Dick-
inson et al., 1999), it is totally plausible that vacant FcRn
would be present on the apical cell surface for a limited time.
Indeed, the authors who noted limited FcRn present in the
neonatal jejunum (Berryman and Rodewald, 1995) also state
that the ex vivo studies measured cell surface FcRn in a ﬁxed
steady-state distribution and do not take into consideration the
rapid rate of receptor recycling which could increase uptake
efﬁciency.
We aimed to examine the contribution of cell surface FcRn in
IgG uptake with non-speciﬁc pinocytosis and endosomal FcRn
binding in our in vivomodel using the high and low FcRn-binders
(N434A andH435A, respectively). The variants were administered
at the duodenum in pH conditions of 6.0, 7.4, and 8.0.
The majority of uptake into the cell was by pinocytosis and
is pH-independent as shown by comparable serum levels of the
FcRn-binding variant, N434A, at pH 7.4 and 8.0. However, when
pH conditions were lowered to 6.0, twice the amount of N434A
was seen in the serum. This was due to extracellular conditions
being optimal for cell surface binding and increased uptake, occur-
ring along with pinocytosis, thereby increasing the number of
FcRn–IgG complexes within the cell. Unbound non-FcRn bind-
ing IgGs (H435A) were also taken up by the cell but are degraded
by lysosomes as they are not protected by FcRn. When the FcRn
high-binder, IgG1 N434A, was administered at the ileum (at pH
6.0), trace levels were observed in the serum conﬁrming the need
for the presence of FcRn for IgGs to pass into the serum (data
not shown). These pH-dependent changes of IgG trancytosis were
not seen in the previous ex vivo study (Benlounes et al., 1995);
however, ex vivo tissue preparation and manipulation may have
affected the cell surface receptor density. Immuno-histochemical
staining in the present study agreed with the in vivo data in
that the greatest staining on the cell surface of enterocytes was
observed at pH 6.0, with less at pH 7.4, and no staining with the
FcRn low-binder, H435A. The immuno-histochemical stainings
were semi-quantitative and are only used as additional evidence
to support the observation that FcRn is present. The possibil-
ity of pinocytosis being increased due to the lowering of the
local pH is also addressed by the pH study being repeated with
administration at the ileum where transcytosis is much lower
due to much less FcRn present. If an increase in pinocytosis
was caused by a decrease in pH, then there should be also be
a difference at this location, albeit much less. However, pH did
not have any effect and transcytosis was remained low in all
conditions.
This pH-dependent increase lends further evidence that FcRn
is also present on the cell surface of the enterocytes in neonatal
mammals.
Unlike oral gavage or feed-tubes which do not allow for bypass
of the harsh acidic conditions of the stomach, the technique of
direct administration into either the duodenum or ileum allows
for conﬁdence that the correct dose of IgG is at the appropriately
tested site for uptake having not been degraded by stomach acids
and proteases. One limitation of the suckling rat pup model as
an in vivo model is during the early postnatal life, the number of
endocytic complex system (including coated pits, apical invagi-
nations, coated vesicles, vesicles, tubules, and endosomes as well
as FcRn) is highly increased to facilitate the absorption of the
macromolecules and IgG ingested from maternal milk, and this
is signiﬁcantly reduced after weaning (Baba et al., 2002); this does
explainwhy low levels of the non-FcRn binding variant, H435A,
were still seen in the serum. However, it is advantageous over the
Ussing chamber as viable animals consist of fully functional cir-
culatory and lymphatic systems which are essential to IgG uptake
from the small intestine.
In summary, intracellular and cell surface FcRn contributes to
IgG uptake into the serum. Increased serum levels of IgG variants
correlated with their FcRn off-rates at pH 7.4. Serum levels were
greatest when administered at the duodenum; the region with
the greatest amount of FcRn. Uptake into the cells for transcy-
tosis could be further potentiated when local environments were
buffered at pH 6.0 to allow for greater binding of IgGs to FcRn
molecules on the cell surface. These results encourage future stud-
ies to evaluate therapeutic IgGs which contain an Fc portion to
promote the advancement of orally available protein therapies.
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